Virginia Retirement Systems ET AL purchased a new stake in Agilent Technologies Inc (NYSE:A) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 41,000 shares of the medical research company’s stock, valued at approximately $3,296,000.
Several other institutional investors have also bought and sold shares of the stock. Captrust Financial Advisors boosted its position in Agilent Technologies by 2,121.1% during the fourth quarter. Captrust Financial Advisors now owns 422 shares of the medical research company’s stock worth $29,000 after purchasing an additional 403 shares in the last quarter. Lake Point Wealth Management purchased a new stake in Agilent Technologies during the fourth quarter worth $30,000. JOYN Advisors Inc. boosted its position in Agilent Technologies by 186.6% during the fourth quarter. JOYN Advisors Inc. now owns 470 shares of the medical research company’s stock worth $32,000 after purchasing an additional 306 shares in the last quarter. Truehand Inc purchased a new stake in Agilent Technologies during the fourth quarter worth $33,000. Finally, We Are One Seven LLC purchased a new stake in Agilent Technologies during the fourth quarter worth $33,000.
Shares of NYSE A traded down $0.35 on Wednesday, hitting $67.97. The company had a trading volume of 4,379,005 shares, compared to its average volume of 2,146,694. Agilent Technologies Inc has a 12-month low of $60.42 and a 12-month high of $82.27. The company has a debt-to-equity ratio of 0.35, a current ratio of 3.41 and a quick ratio of 2.79. The company has a market capitalization of $21.77 billion, a price-to-earnings ratio of 24.36, a PEG ratio of 1.93 and a beta of 1.33.
Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Tuesday, May 14th. The medical research company reported $0.71 EPS for the quarter, missing analysts’ consensus estimates of $0.72 by ($0.01). The business had revenue of $1.24 billion during the quarter, compared to analysts’ expectations of $1.27 billion. Agilent Technologies had a net margin of 22.25% and a return on equity of 19.71%. The company’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same period in the prior year, the company posted $0.65 EPS. Research analysts expect that Agilent Technologies Inc will post 3.05 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 24th. Investors of record on Tuesday, July 2nd will be issued a $0.164 dividend. This represents a $0.66 dividend on an annualized basis and a yield of 0.97%. Agilent Technologies’s dividend payout ratio is currently 23.66%.
A number of analysts have commented on the company. Zacks Investment Research downgraded Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Thursday, May 16th. Bank of America cut their price target on Agilent Technologies from $88.00 to $82.00 and set a “buy” rating for the company in a report on Wednesday, May 15th. Deutsche Bank cut their price target on Agilent Technologies from $90.00 to $85.00 and set a “buy” rating for the company in a report on Wednesday, May 15th. Barclays dropped their target price on Agilent Technologies from $88.00 to $86.00 and set an “overweight” rating for the company in a research note on Wednesday, May 15th. Finally, Cowen upped their target price on Agilent Technologies from $80.00 to $90.00 and gave the company an “outperform” rating in a research note on Tuesday, March 26th. Three equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $86.58.
In other Agilent Technologies news, SVP Michael Tang sold 6,728 shares of the company’s stock in a transaction that occurred on Wednesday, March 27th. The stock was sold at an average price of $80.50, for a total transaction of $541,604.00. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, VP Mark Doak sold 16,421 shares of the company’s stock in a transaction that occurred on Friday, February 22nd. The shares were sold at an average price of $77.95, for a total value of $1,280,016.95. The disclosure for this sale can be found here. Insiders sold 48,583 shares of company stock valued at $3,855,924 in the last three months.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
Featured Story: What is the Consumer Price Index (CPI)?
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.